224 related articles for article (PubMed ID: 30838442)
1. Predictive value of the Ki67 index for lymph node metastasis of small non-functioning pancreatic neuroendocrine neoplasms.
Masui T; Sato A; Nakano K; Uchida Y; Yogo A; Anazawa T; Nagai K; Kawaguchi Y; Takaori K; Uemoto S
Surg Today; 2019 Jul; 49(7):593-600. PubMed ID: 30838442
[TBL] [Abstract][Full Text] [Related]
2. The number of positive nodes accurately predicts recurrence after pancreaticoduodenectomy for nonfunctioning neuroendocrine neoplasms.
Partelli S; Javed AA; Andreasi V; He J; Muffatti F; Weiss MJ; Sessa F; La Rosa S; Doglioni C; Zamboni G; Wolfgang CL; Falconi M
Eur J Surg Oncol; 2018 Jun; 44(6):778-783. PubMed ID: 29610023
[TBL] [Abstract][Full Text] [Related]
3. Significance of lymph node metastasis in pancreatic neuroendocrine tumor.
Taki K; Hashimoto D; Nakagawa S; Ozaki N; Tomiyasu S; Ohmuraya M; Arima K; Kaida T; Higashi T; Sakamoto K; Sakata K; Okabe H; Nitta H; Hayashi H; Chikamoto A; Beppu T; Takamori H; Hirota M; Baba H
Surg Today; 2017 Sep; 47(9):1104-1110. PubMed ID: 28229300
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the Site and Frequency of Lymph Node Metastasis with Non-Functioning Pancreatic Neuroendocrine Tumor.
Izumo W; Higuchi R; Furukawa T; Yazawa T; Uemura S; Shiihara M; Yamamoto M
Eur Surg Res; 2019; 60(5-6):219-228. PubMed ID: 31734661
[TBL] [Abstract][Full Text] [Related]
5. Comparison of Recurrence Between Pancreatic and Duodenal Neuroendocrine Neoplasms After Curative Resection: A Single-Institution Analysis.
Masui T; Sato A; Nakano K; Uchida Y; Yogo A; Anazawa T; Nagai K; Kawaguchi Y; Takaori K; Uemoto S
Ann Surg Oncol; 2018 Feb; 25(2):528-534. PubMed ID: 29164413
[TBL] [Abstract][Full Text] [Related]
6. Lesion-by-lesion correlation between uptake at FDG PET and the Ki67 proliferation index in resected pancreatic neuroendocrine tumors.
de Mestier L; Armani M; Cros J; Hentic O; Rebours V; Cadiot G; Sauvanet A; Couvelard A; Lebtahi R; Ruszniewski P
Dig Liver Dis; 2019 Dec; 51(12):1720-1724. PubMed ID: 31350186
[TBL] [Abstract][Full Text] [Related]
7. Do morphologic characteristics play a role in nodal metastatic progression of well-differentiated pancreatic neuroendocrine tumors?
Ugras N; Hasdemir S; Yerci Ö; Taşar P; Dündar HZ; Macunluoğlu AC
Tumori; 2021 Feb; 107(1):80-85. PubMed ID: 32705937
[TBL] [Abstract][Full Text] [Related]
8. Recurrence of Pancreatic Neuroendocrine Tumors and Survival Predicted by Ki67.
Genç CG; Falconi M; Partelli S; Muffatti F; van Eeden S; Doglioni C; Klümpen HJ; van Eijck CHJ; Nieveen van Dijkum EJM
Ann Surg Oncol; 2018 Aug; 25(8):2467-2474. PubMed ID: 29789972
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathological features of small nonfunctioning pancreatic neuroendocrine tumors.
Furukori M; Imai K; Karasaki H; Watanabe K; Oikawa K; Miyokawa N; Taniguchi M; Furukawa H
World J Gastroenterol; 2014 Dec; 20(47):17949-54. PubMed ID: 25548493
[TBL] [Abstract][Full Text] [Related]
10. Association between axillary lymph node status and Ki67 labeling index in triple-negative medullary breast carcinoma.
Chu Z; Lin H; Liang X; Huang R; Tang J; Bao Y; Jiang J; Zhan Q; Zhou X
Jpn J Clin Oncol; 2015 Jul; 45(7):637-41. PubMed ID: 25862826
[TBL] [Abstract][Full Text] [Related]
11. Neuroendocrine tumor G3: a pancreatic well-differentiated neuroendocrine tumor with a high proliferative rate.
Tanaka H; Matsusaki S; Baba Y; Isono Y; Kumazawa H; Sase T; Okano H; Saito T; Mukai K; Kaneko H
Clin J Gastroenterol; 2015 Dec; 8(6):414-20. PubMed ID: 26439620
[TBL] [Abstract][Full Text] [Related]
12. Grading of well-differentiated pancreatic neuroendocrine tumors is improved by the inclusion of both Ki67 proliferative index and mitotic rate.
McCall CM; Shi C; Cornish TC; Klimstra DS; Tang LH; Basturk O; Mun LJ; Ellison TA; Wolfgang CL; Choti MA; Schulick RD; Edil BH; Hruban RH
Am J Surg Pathol; 2013 Nov; 37(11):1671-7. PubMed ID: 24121170
[TBL] [Abstract][Full Text] [Related]
13. Lymph node sampling rates and predictors of nodal metastasis in pancreatic neuroendocrine tumor resections: the UCSF experience with 149 patients.
Parekh JR; Wang SC; Bergsland EK; Venook AP; Warren RS; Kim GE; Nakakura EK
Pancreas; 2012 Aug; 41(6):840-4. PubMed ID: 22781907
[TBL] [Abstract][Full Text] [Related]
14. Morphological and immunohistochemical features of neuroendocrine neoplasms in gastroenteropancreatic tract.
Živojinov M; Panić Ž; Ilić A; Ilić Sabo J; Vasilijević M; Lakić T
Arab J Gastroenterol; 2023 Feb; 24(1):24-28. PubMed ID: 35927198
[TBL] [Abstract][Full Text] [Related]
15. Prediction of lymph node metastasis in pancreatic neuroendocrine tumors by contrast enhancement characteristics.
Mizumoto T; Toyama H; Terai S; Mukubou H; Yamashita H; Shirakawa S; Nanno Y; Sofue K; Kido M; Ajiki T; Fukumoto T
Pancreatology; 2017; 17(6):956-961. PubMed ID: 28964660
[TBL] [Abstract][Full Text] [Related]
16. The role of lymph node ratio in recurrence after curative surgery for pancreatic endocrine tumours.
Ricci C; Casadei R; Taffurelli G; Buscemi S; D'Ambra M; Monari F; Santini D; Campana D; Tomassetti P; Minni F
Pancreatology; 2013; 13(6):589-93. PubMed ID: 24280574
[TBL] [Abstract][Full Text] [Related]
17. Analysis of lymph node metastasis in pancreatic neuroendocrine tumors (PNETs) based on the tumor size and hormonal production.
Tsutsumi K; Ohtsuka T; Mori Y; Fujino M; Yasui T; Aishima S; Takahata S; Nakamura M; Ito T; Tanaka M
J Gastroenterol; 2012 Jun; 47(6):678-85. PubMed ID: 22350698
[TBL] [Abstract][Full Text] [Related]
18. Comparison of Tumor Markers for Predicting Disease-Free Survival in Surgically Resected Pancreatic Neuroendocrine Tumors.
Zhou B; Fang B; Yan S; Wang W
Clin Lab; 2017 Jul; 63(7):1251-1259. PubMed ID: 28792692
[TBL] [Abstract][Full Text] [Related]
19. Pancreatic neuroendocrine tumors: Preoperative factors that predict lymph node metastases to guide operative strategy.
Postlewait LM; Ethun CG; Baptiste GG; Le N; McInnis MR; Cardona K; Russell MC; Sarmiento JM; Kooby DA; Staley CA; Maithel SK
J Surg Oncol; 2016 Sep; 114(4):440-5. PubMed ID: 27334541
[TBL] [Abstract][Full Text] [Related]
20. Machine learning-based model for prediction and feature analysis of recurrence in pancreatic neuroendocrine tumors G1/G2.
Murakami M; Fujimori N; Nakata K; Nakamura M; Hashimoto S; Kurahara H; Nishihara K; Abe T; Hashigo S; Kugiyama N; Ozawa E; Okamoto K; Ishida Y; Okano K; Takaki R; Shimamatsu Y; Ito T; Miki M; Oza N; Yamaguchi D; Yamamoto H; Takedomi H; Kawabe K; Akashi T; Miyahara K; Ohuchida J; Ogura Y; Nakashima Y; Ueki T; Ishigami K; Umakoshi H; Ueda K; Oono T; Ogawa Y
J Gastroenterol; 2023 Jun; 58(6):586-597. PubMed ID: 37099152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
